Aridis Pharmaceuticals Is A Biopharmaceutical Company Based In San Josecaliforniathe Company Focuses On Discovering And Developing Innovative Drug Candidates To Prevent And Treat Life Threatening Infectious Diseasesparticularly Those Caused By Antimicrobial Resistant Pathogens And Viral Pandemicsaridis Aims To Enhance Current Treatment Standards With Its Therapeutic Monoclonal Antibodies And Novel Anti Infectives The Company Employs Proprietary Technology Platformsincluding A Pex And Mabigxa To Develop Human Derived Monoclonal Antibodies From Infection Survivorsthis Technology Allows For The Recovery And Immortalization Of Antibody Producing Cellswhich Are Used To Create Therapeutic Antibodies That Effectively Neutralize Pathogensaridis Has A Diverse Product Pipelinefeaturing Candidates Like Ar 301 For Ventilator Associated Pneumoniaar 320 For Prevention Of Vapar 501 To Combat Antibiotic Resistanceand Ar 701 Targeting The Sars Cov 2 Virusadditionallyaridis Is Advancing Macromolecular Stabilization Technology To Improve Vaccine Stability
